Centene — Feb 4, 2025 release

In total, the Company repurchased 42.0 million shares for $3.0 billion through the stock repurchase program for the full year 2024. As of February 4, 2025, $2.2 billion remains available under the Company's stock repurchase program. Outlook The Company is increasing its 2025 premium and service revenues guidance range by $4.0 billion to a range of $158.0 billion to $160.0 billion to reflect the following expectations: • outperformance in our PDP annual enrollment resulting in an additional $1.5 billion premium revenue, • outperformance in our Medicare Advantage annual enrollment resulting in $1.0 billion of additional premium revenue, and • $1.5 billion of additional Medicaid premium revenue due to a program change adding behavioral health coverage in one of our state contracts. The Company reiterates its 2025 GAAP diluted EPS guidance floor of greater than $6.19 and its 2025 adjusted diluted EPS guidance floor of greater than $7.25. Conference Call As previously announced, the Company will host a conference call Tuesday, February 4, 2025, at 8:30 a.m. ET to review the financial results for the fourth quarter and year ended December 31, 2024. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com , under the Investors section. A webcast replay will be available for on-demand listening shortly fo